People: Jamaica Potts Szeliga, Partner

Photo of Jamaica Potts Szeliga, Partner

Jamaica Potts Szeliga

Partner

Washington, D.C.
Direct: (202) 828-5364
0
Jamaica Szeliga is a partner in the Litigation Department of Seyfarth Shaw LLP’s Washington, D.C. office.  
 
Ms. Szeliga’s practice focuses primarily on intellectual property litigation relating to pharmaceutical, biotechnology, and chemical matters.  She also litigates patent disputes involving other technologies, including medical devices, mechanical inventions, communications, and high tech products, and further has significant experience in design patent litigation.
 
With respect to litigation, Ms. Szeliga has participated in several bench and jury trials and managed litigations at all stages.  As part of her experiences, Ms. Szeliga has drafted and argued dispositive motions, coordinated complex fact discovery, managed expert discovery, taken and defended fact and expert depositions, examined witnesses at trial,  engaged in mediation and dispute resolution processes, and briefed multiple appeals.  She also has been a member of several joint defense groups, and has litigated against such groups, particularly in the context of Hatch-Waxman ANDA matters.
 
Ms. Szeliga’s practice also extends to counseling on the Biologics Price Competition and Innovation Act (the “BPCIA”), patent prosecution, opinion drafting, and providing advice relating to intellectual property corporate transactions.
 
Ms. Szeliga graduated magna cum laude from Harvard Law School in 2002, and received her Bachelor of Science degree in Chemistry, with a minor in Biology, with distinction, from Stanford University in 1999. She is admitted to the District of Columbia and the New York State bar and is registered to practice before the United States Patent and Trademark Office.
Jamaica Szeliga is a partner in the Litigation Department of Seyfarth Shaw LLP’s Washington, D.C. office.  
 
Ms. Szeliga’s practice focuses primarily on intellectual property litigation relating to pharmaceutical, biotechnology, and chemical matters.  She also litigates patent disputes involving other technologies, including medical devices, mechanical inventions, communications, and high tech products, and further has significant experience in design patent litigation.
 
With respect to litigation, Ms. Szeliga has participated in several bench and jury trials and managed litigations at all stages.  As part of her experiences, Ms. Szeliga has drafted and argued dispositive motions, coordinated complex fact discovery, managed expert discovery, taken and defended fact and expert depositions, examined witnesses at trial,  engaged in mediation and dispute resolution processes, and briefed multiple appeals.  She also has been a member of several joint defense groups, and has litigated against such groups, particularly in the context of Hatch-Waxman ANDA matters.
 
Ms. Szeliga’s practice also extends to counseling on the Biologics Price Competition and Innovation Act (the “BPCIA”), patent prosecution, opinion drafting, and providing advice relating to intellectual property corporate transactions.
 
Ms. Szeliga graduated magna cum laude from Harvard Law School in 2002, and received her Bachelor of Science degree in Chemistry, with a minor in Biology, with distinction, from Stanford University in 1999. She is admitted to the District of Columbia and the New York State bar and is registered to practice before the United States Patent and Trademark Office.

Education

  • J.D., Harvard Law School, magna cum laude (2002)

  • B.S. in Chemistry, Stanford University, with distinction (2002)
    Minor in Biology

Admissions

  • District of Columbia
  • New York
  • Registered Patent Attorney, U.S. Patent and Trademark Office

Courts

  • U.S. Supreme Court
  • U.S. Court of Appeals for the Federal Circuit
  • D.C. Court of Appeals
  • New York Court of Appeals

Affiliations

  • American Bar Association
  • The Federal Circuit Bar Association
  • The American Chemical Society
  • The Washington Area Lawyers for the Arts

Presentations

  • “The BPCIA Patent Dance - What Biosimilar Companies Need to Know,” presented by The Knowledge Group (January 10, 2017)
  • “USPTO’s Proposed Changes to AIA Post-Grant Amendment Proceedings:  Preparing for the Big Shift,” presented by The Knowledge Group (March 29, 2016)

Accolades

  • Named in the Washington, D.C. Rising Stars list, as published in Washington D.C. Super Lawyers, 2016